Skip to content

Effect of blood letting in indralupta

Effect of Prachchana Karma and Malatyadi Taila Application in the management of indralupta with special reference to Alopecia areata a randomized clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062942
Enrollment
20
Registered
2024-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L638- Other alopecia areata

Interventions

None listed

Sponsors

Dr Sushree Saswati Nayak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Alopecia Areata Patient selected irrespective of any of caste gender religion and occupation

Exclusion criteria

Exclusion criteria: Patients who have been diagnosed to have local disease like Androgenetic Alopecia AlopeciaTotalis Alopecia Universalis Scarring hair lossPatients with furuncles pustules oozing skin lesion over scalp were excluded CT above 8 minutes BT above 5 minutes will be excluded

Design outcomes

Primary

MeasureTime frame
To assess the effect of prachchhana karmaTimepoint: Baeseline 30 days

Secondary

MeasureTime frame
To evaluate the effect of application of Malatyadi Taila in the management of IndraluptaTimepoint: Baseline 30 days

Countries

India

Contacts

Public ContactDr Kalmesh S Sangolli

KAHERs BM Kankanawadi Ayurveda Mahavidyalaya

drksskle@gmail.com9448266969

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026